Literature DB >> 2186542

Management of the obstructed urinary tract associated with neurogenic bladder dysfunction.

S B Bauer1, D B Joseph.   

Abstract

The child with neurogenic bladder dysfunction may suffer from lower urinary tract obstruction, which, if untreated, can result in upper urinary tract deterioration. It is prudent to identify those newborns and infants who are at risk for upper urinary tract deterioration and advise an appropriate treatment protocol. In order to identify those children at risk, a thorough examination is required, along with appropriate upper urinary tract imaging studies and urodynamic assessment of the bladder. Infants and children at risk for upper tract deterioration are those who have intermittent or continuous detrusor pressure elevation above 40 cm H2O. We have identified the safe period, which is the time during which the bladder remains at a pressure lower than 40 cm H2O. Our management protocol for each child is individualized and based on increasing the safe period. The safe period can be increased with a combination of intermittent catheterization, administration of medications, and, in some cases, surgical reconstruction. With compulsive evaluation and intensive management, many of the previous upper urinary tract changes associated with the obstructed neurogenic bladder can be averted. With the above factors in mind, we have defined the period of bladder filling and storage where the pressure is below 40 cm H2O as the safe period. The ideal bladder for maintenance of normal upper tracts would have a long safe period and low voiding pressure. Our treatment protocol for the neurogenic bladder is therefore dependent on identifying those children who have very short or nonexistent safe periods. These are the children who are at risk for upper tract deterioration.

Entities:  

Mesh:

Year:  1990        PMID: 2186542

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  5 in total

Review 1.  Current approaches to the urologic care of children with spina bifida.

Authors:  David B Joseph
Journal:  Curr Urol Rep       Date:  2008-03       Impact factor: 3.092

2.  Baseline Urinary Tract Imaging in Infants Enrolled in the UMPIRE Protocol for Children with Spina Bifida.

Authors:  Stacy T Tanaka; Pangaja Paramsothy; Judy Thibadeau; John S Wiener; David B Joseph; Earl Y Cheng; Duong Tu; Christopher Austin; Chester J Koh; M Chad Wallis; William O Walker; Kathryn A Smith; Jonathan C Routh; Michelle A Baum
Journal:  J Urol       Date:  2019-06       Impact factor: 7.450

3.  Treatment outcomes according to neuropathic bladder sphincter dysfunction type after treatment of oxybutynin chloride in children with myelodysplasia.

Authors:  Minki Baek; Jung Yoon Kang; Jeongyun Jeong; Dae Kyung Kim; Kwang Myung Kim
Journal:  Int Urol Nephrol       Date:  2013-03-31       Impact factor: 2.370

Review 4.  The neurogenic bladder: medical treatment.

Authors:  Carla Verpoorten; Gunnar M Buyse
Journal:  Pediatr Nephrol       Date:  2007-12-19       Impact factor: 3.714

Review 5.  Preventing kidney injury in children with neurogenic bladder dysfunction.

Authors:  Faezeh Javadi Larijani; Mastaneh Moghtaderi; Nilofar Hajizadeh; Farahnak Assadi
Journal:  Int J Prev Med       Date:  2013-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.